Risk of second breast cancer according to estrogen receptor status and family history. (Q44558762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Risk of second breast cancer according to estrogen receptor status and family history (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Simone Benhamou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

10

Elisabetta Rapiti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1

Christine Bouchardy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

9

Georges Vlastos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Gérald Fioretta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Helena M Verkooijen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Pierre O Chappuis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Isabelle Neyroud-Caspar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Monica Castiglione

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

English

0 references

publication date

29 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

14 February 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

233-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-010-1137-z

14 February 2020

exact match

0 references

cites work

Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Concordance of the hormone receptors and correlation of HER-2/neu overexpression of the metachronous cancers of contralateral breasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

A comparison of bilateral breast cancers in BRCA carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Epidemiologic and molecular risk factors for contralateral breast cancer among young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Clinical epidemiology of breast cancer in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Second primary breast cancer occurrence according to hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Tumor marker phenotype concordance in second primary breast cancer, California, 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1137-Z

10.1007/S10549-010-1137-Z

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878464%20AND%20SRC:MED&resulttype=core&format=json

release_saqgm2hq7bav3i32d2ly6rraie

14 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/saqgm2hq7bav3i32d2ly6rraie

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference